Inspire Medical Systems, Inc. Interest Expense Nonoperating
Inspire Medical Systems, Inc. (INSP) reported Interest Expense Nonoperating of $137.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2026-02-13
- Inspire Medical Systems, Inc. interest expense nonoperating for the quarter ending 2025-12-31 was $122.00K, a 454.55% increase year-over-year.
- Inspire Medical Systems, Inc. interest expense nonoperating for the quarter ending 2025-09-30 was $11.00K.
- Inspire Medical Systems, Inc. interest expense nonoperating for the quarter ending 2025-06-30 was $4.00K.
- Inspire Medical Systems, Inc. interest expense nonoperating for the quarter ending 2025-03-31 was $0.00.
- Inspire Medical Systems, Inc. interest expense nonoperating for fiscal 2025 was $137.00K, a 522.73% increase from fiscal 2024.
- Inspire Medical Systems, Inc. interest expense nonoperating for fiscal 2024 was $22.00K.
- Inspire Medical Systems, Inc. interest expense nonoperating for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Inspire Medical Systems, Inc. interest expense nonoperating for fiscal 2022 was $1.68M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2025-12-31 | $122.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $133.00K derived: sum of 2 quarters · filed 2026-02-13 | $137.00K derived: sum of 3 quarters · filed 2026-02-13 | $137.00K 10-K · filed 2026-02-13 |
| 2025-09-30 | $11.00K 10-Q · filed 2025-11-03 | $15.00K derived: sum of 2 quarters · filed 2025-11-03 | $15.00K 10-Q · filed 2025-11-03 | $37.00K derived: sum of 4 quarters · filed 2026-02-13 |
| 2025-06-30 | $4.00K 10-Q · filed 2025-08-04 | $4.00K 10-Q · filed 2025-08-04 | $26.00K derived: sum of 3 quarters · filed 2026-02-13 | $26.00K derived: sum of 4 quarters · filed 2026-02-13 |
| 2025-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2026-02-13 | $22.00K derived: sum of 2 quarters · filed 2026-02-13 | $22.00K derived: sum of 3 quarters · filed 2026-02-13 | $22.00K derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $22.00K derived: sum of 2 quarters · filed 2026-02-13 | $22.00K derived: sum of 3 quarters · filed 2026-02-13 | $22.00K 10-K · filed 2026-02-13 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-03 | $0.00 derived: sum of 2 quarters · filed 2025-11-03 | $0.00 10-Q · filed 2025-11-03 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-04 | $0.00 10-Q · filed 2025-08-04 | ||
| 2023-12-31 | $0.00 10-K · filed 2026-02-13 | |||
| 2022-12-31 | $1.68M 10-K · filed 2025-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |